LifeStance Health Group (NASDAQ:LFST) Earns Overweight Rating from Analysts at Barclays

by · The Markets Daily

Barclays started coverage on shares of LifeStance Health Group (NASDAQ:LFST – Free Report) in a research note published on Tuesday, MarketBeat.com reports. The brokerage issued an overweight rating and a $8.00 price target on the stock.

LFST has been the subject of several other reports. UBS Group increased their price objective on LifeStance Health Group from $9.00 to $10.00 and gave the company a “buy” rating in a research note on Friday, November 7th. BMO Capital Markets assumed coverage on shares of LifeStance Health Group in a research report on Thursday, November 13th. They issued an “outperform” rating and a $8.00 target price for the company. Zacks Research lowered shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 5th. BTIG Research upped their price objective on shares of LifeStance Health Group from $8.00 to $9.00 and gave the company a “buy” rating in a research note on Thursday, November 6th. Finally, Wall Street Zen downgraded shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $8.86.

View Our Latest Research Report on LifeStance Health Group

LifeStance Health Group Stock Up 0.1%

LifeStance Health Group stock opened at $6.76 on Tuesday. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.58 and a quick ratio of 1.58. The stock has a market capitalization of $2.63 billion, a PE ratio of -225.33 and a beta of 1.13. The business has a 50 day simple moving average of $5.81 and a 200-day simple moving average of $5.33. LifeStance Health Group has a 12 month low of $3.74 and a 12 month high of $8.30.

LifeStance Health Group (NASDAQ:LFST – Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The company had revenue of $363.81 million during the quarter, compared to analysts’ expectations of $355.06 million. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The firm’s revenue for the quarter was up 16.3% on a year-over-year basis. During the same period in the prior year, the business posted ($0.02) earnings per share. On average, analysts anticipate that LifeStance Health Group will post -0.18 EPS for the current fiscal year.

Insider Activity

In related news, insider Lisa K. Miller sold 57,240 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $6.43, for a total value of $368,053.20. Following the transaction, the insider directly owned 261,292 shares in the company, valued at approximately $1,680,107.56. This represents a 17.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 3.20% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On LifeStance Health Group

Large investors have recently modified their holdings of the business. Tudor Investment Corp ET AL purchased a new position in shares of LifeStance Health Group during the 3rd quarter worth $1,040,000. CIBC Bancorp USA Inc. acquired a new stake in shares of LifeStance Health Group during the third quarter valued at about $78,000. Jacobs Levy Equity Management Inc. increased its position in shares of LifeStance Health Group by 1.8% during the third quarter. Jacobs Levy Equity Management Inc. now owns 2,147,690 shares of the company’s stock valued at $11,812,000 after acquiring an additional 38,528 shares during the last quarter. Dark Forest Capital Management LP acquired a new position in shares of LifeStance Health Group in the 3rd quarter worth approximately $140,000. Finally, PharVision Advisers LLC acquired a new stake in LifeStance Health Group in the 3rd quarter valued at approximately $84,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

(Get Free Report)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Read More